SkyCity announces earnings for FY2025
Casino Slot Machine. Source: Shutterstock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

SkyCity Entertainment Group (ASX: SKC | NZX: SKC) has announced a the group expects to see a EBITDA fall around 4% to $245 million.

CEO Jason Walbridge says: “The difficult market conditions that businesses like ours – which are reliant on discretionary consumer spending – continue to have a significant impact on both our revenue and earning”

The SkyCity group owns five casinos in Australia and New Zealand: SkyCity Auckland, SkyCity Hamilton, SkyCity Queenstown, SkyCity Wharf Casino and SkyCity Adelaide.

Walbridge continues with “Notwithstanding these challenging consitions, we remain optimistic that as consumer confidence returns and spend begins to lift, SkyCity is well placed to maximise the opportunities in front of us, like the New Zealand International Convention Centre opening in February 2026”

Full release can be here.

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

SKC by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…